CAMpania PugliA bRanch Iliaco

NCT ID: NCT06946381

Last Updated: 2025-04-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-01-01

Study Completion Date

2028-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Spontaneus Multicentric Observational registry to investigate the medium and long-term performances of the Iliac E-liac Branch Device from Artivion for treatment of Aortoiliac aneurysms in a real-world consecutive patients cohort.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aortoiliac Aneurysm Iliac Aneurysm

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MAIN

Consecutive patients treated with the e-liac device

Evar

Intervention Type PROCEDURE

Branch Evar with the e-liac device

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Evar

Branch Evar with the e-liac device

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* An aortoiliac or aortic aneurysm of surgical interest based on the most recent local guidelines treated with the E-liac stent-graft system, alone or in combination with other devices

Exclusion Criteria

* Patient's refusal to be enrolled in the registry
* Patient treated with devices not including the E-liac stent-graft system
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Bari

OTHER

Sponsor Role collaborator

Federico II University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Umberto Marcello Bracale

Prof.

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Azienda ospedaliero-universitaria consorziale policlinico di Bari

Bari, BA, Italy

Site Status RECRUITING

Azienda Ospedaliera Universitaria Federico II

Naples, , Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Umberto Marcello UM Bracale, PhD, Prof.

Role: CONTACT

081 746 2629

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Domenico D Angiletta, PhD, Prof.

Role: primary

+ 39 080 559 1111

Umberto Marcello UM Bracale, PhD, Prof

Role: primary

+ 39 081 746 2629

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CAMPARI

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.